Peru

In Peru there were over 4,000 new cervical cancer cases in 2023, ranking as the second most frequent cancer among women aged 15 to 44, with mortality exceeding 2,000 cases annually (ICO/IARC, 2023). The COVID-19 pandemic disrupted surveillance efforts, resulting in a decrease of up to 76% of cervical cancer screening tests. This project aims to increase early diagnosis, improve wait times and the user experience to reduce preventable morbidity and mortality among female cancer patients.

https://movement-health.org.linux99.curanetserver.dk/region-explore/latin-america/